Answers · Grant
Who can apply for Advancing innovation in accelerated cancer diagnosis?
Innovate UK, on behalf of the Office for Life Sciences’ (OLS) Cancer Healthcare Goals programme, will invest up to £25.4 million, to support the clinical validation and evaluation of early cancer diagnostic technologies and devices.
- Funder: Innovate UK, on behalf of the Office for Life Sciences’ (OLS).
- Who the source lists: Public Sector, Non-profit, Private Sector.
- Where: National.
- The published range is £1.5 million to £4 million.
- Opens 2026-09-01. Closes 2026-10-28.
Indicative only. Not advice. Confirm it on the official page before you rely on it.